164 related articles for article (PubMed ID: 24280704)
21. In vitro synergism of magnolol and honokiol in combination with antibacterial agents against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA).
Zuo GY; Zhang XJ; Han J; Li YQ; Wang GC
BMC Complement Altern Med; 2015 Dec; 15():425. PubMed ID: 26627468
[TBL] [Abstract][Full Text] [Related]
22. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
23. Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Hallesy J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 Sep; 59(9):5529-34. PubMed ID: 26124162
[TBL] [Abstract][Full Text] [Related]
24. Antibacterial activity of stilbene oligomers against vancomycin-resistant Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) and their synergism with antibiotics.
Sakagami Y; Sawabe A; Komemushi S; All Z; Tanaka T; Iliya I; Iinuma M
Biocontrol Sci; 2007 Mar; 12(1):7-14. PubMed ID: 17408003
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
[TBL] [Abstract][Full Text] [Related]
26. Salicylanilide carbamates: Promising antibacterial agents with high in vitro activity against methicillin-resistant Staphylococcus aureus (MRSA).
Zadrazilova I; Pospisilova S; Masarikova M; Imramovsky A; Ferriz JM; Vinsova J; Cizek A; Jampilek J
Eur J Pharm Sci; 2015 Sep; 77():197-207. PubMed ID: 26079401
[TBL] [Abstract][Full Text] [Related]
27.
Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
[TBL] [Abstract][Full Text] [Related]
28. Antagonistic Effect of Colistin on Vancomycin Activity against Methicillin-Resistant Staphylococcus aureus in
Choi S; Moon SM; Park SJ; Lee SC; Jung KH; Sung HS; Kim MN; Jung J; Kim MJ; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS; Chong YP
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32041713
[TBL] [Abstract][Full Text] [Related]
29. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients.
Gonzalez N; Sevillano D; Alou L; Cafini F; Gimenez MJ; Gomez-Lus ML; Prieto J; Aguilar L
J Antimicrob Chemother; 2013 Oct; 68(10):2291-5. PubMed ID: 23674766
[TBL] [Abstract][Full Text] [Related]
30. Vancomycin Minimum Inhibitory Concentration for Methicillin-Resistant Staphylococcus aureus Infections; Is There Difference in Mortality Between Patients?
Aminzadeh Z; Yadegarynia D; Fatemi A; Tahmasebian Dehkordi E; Azad Armaki S
Jundishapur J Microbiol; 2014 Oct; 7(10):e12831. PubMed ID: 25632329
[TBL] [Abstract][Full Text] [Related]
31. [In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Sato S; Miura T; Kudo E; Kudo Y; Saitoh Y; Kimpara I; Tsujino M; Kudo H
Jpn J Antibiot; 1997 Aug; 50(8):711-6. PubMed ID: 9339397
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological synergism of bee venom and melittin with antibiotics and plant secondary metabolites against multi-drug resistant microbial pathogens.
Al-Ani I; Zimmermann S; Reichling J; Wink M
Phytomedicine; 2015 Feb; 22(2):245-55. PubMed ID: 25765829
[TBL] [Abstract][Full Text] [Related]
33. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Smith JR; Yim J; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
[TBL] [Abstract][Full Text] [Related]
34. A promising antibiotic, synergistic and antibiofilm effects of Vernonia condensata Baker (Asteraceae) on Staphylococcus aureus.
da Silva JB; de Bessa ME; Santos Mayorga OA; Andrade VT; da Costa YFG; de Freitas Mendes R; Pires Ferreira AL; Scio E; Alves MS
Microb Pathog; 2018 Oct; 123():385-392. PubMed ID: 30053603
[TBL] [Abstract][Full Text] [Related]
35. A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
Akram FE; El-Tayeb T; Abou-Aisha K; El-Azizi M
Ann Clin Microbiol Antimicrob; 2016 Aug; 15(1):48. PubMed ID: 27530257
[TBL] [Abstract][Full Text] [Related]
36. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration.
Chen SY; Liao CH; Wang JL; Chiang WC; Lai MS; Chie WC; Chen WJ; Chang SC; Hsueh PR
Clin Infect Dis; 2012 Nov; 55(10):1329-37. PubMed ID: 22911641
[TBL] [Abstract][Full Text] [Related]
37. The impact of serum vancomycin levels and minimum inhibitory concentrations of methicillin-resistant Staphylococcus aureus on mortality in patients with nosocomial pneumonia.
Machado DP; Goldani LZ; Paiva RM; Aquino VR; de-Paris F; Lisboa T; Jung B; Dos Santos RP
Can J Infect Dis Med Microbiol; 2013; 24(3):e75-9. PubMed ID: 24421835
[TBL] [Abstract][Full Text] [Related]
38. Multiple Low Frequency Ultrasound Enhances Bactericidal Activity of Vancomycin against Methicillin-Resistant
Wang J; Wen K; Liu X; Weng CX; Wang R; Cai Y
Biomed Res Int; 2018; 2018():6023101. PubMed ID: 30364019
[TBL] [Abstract][Full Text] [Related]
39. Significant antibacterial activity and synergistic effects of camel lactoferrin with antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).
Redwan EM; El-Baky NA; Al-Hejin AM; Baeshen MN; Almehdar HA; Elsaway A; Gomaa AB; Al-Masaudi SB; Al-Fassi FA; AbuZeid IE; Uversky VN
Res Microbiol; 2016; 167(6):480-91. PubMed ID: 27130281
[TBL] [Abstract][Full Text] [Related]
40. [In vitro activities of quinupristin/dalfopristin in combination with vancomycin and gatifloxacin against Staphylococcus aureus and Enterococcus faecium clinical isolates].
Gülden E; Ermertcan S
Mikrobiyol Bul; 2009 Jan; 43(1):53-60. PubMed ID: 19334380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
